BUKWANG PHARMACEUTICAL Holds IR Meeting for Q1 2026 Earnings and R&D Update
BUKWANG PHARMACEUTICAL will hold an IR meeting via conference call on April 21, 2026 at 3:00 PM for institutional investors, analysts, and media.
The purpose is to discuss Q1 2026 financial results and R&D progress, organized by the company itself.
IR materials will be posted on the company's website prior to the event, and the schedule may change.
[AI Summary]This disclosure is a routine announcement of an IR meeting for regular earnings release. No capital raising or share-related issues are involved, so the impact on stock price is expected to be neutral.